deferoxamine has been researched along with Red-Cell Aplasia, Pure in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuer, W | 1 |
| Ronson, A | 1 |
| Slotki, IN | 1 |
| Abramov, A | 1 |
| Hershko, C | 1 |
| Cabantchik, ZI | 1 |
| Schafer, AI | 1 |
| Rabinowe, S | 1 |
| Le Boff, MS | 1 |
| Bridges, K | 1 |
| Cheron, RG | 1 |
| Dluhy, R | 1 |
2 other studies available for deferoxamine and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.
Topics: beta-Thalassemia; Chelating Agents; Deferoxamine; Dietary Supplements; Drug Monitoring; Enzyme-Linke | 2000 |
Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
Topics: Adult; Anemia; Blood Glucose; Deferoxamine; Glucose Tolerance Test; Hemosiderosis; Humans; Iron; Iro | 1985 |